UC project a finalist for Fast Company's World Changing Ideas Awards
AntiOD was recognized in the Health and Wellness category by the business publication
A University of Cincinnati design project aimed at making opioid overdose reversal medication more accessible has been recognized by Fast Company.
AntiOD was named a finalist in the Health and Wellness category for the publication's World Changing Ideas Awards. The project was created by Claudia Rebola, assistant professor in UC's College of Design, Architecture, Art, and Planning, and a team of DAAP graduate students. They developed a naloxone-dispensing smart device to help combat the opioid epidemic. The dispensers are expected to be installed across Cincinnati this spring.
Fast Company‘s third annual World Changing Ideas Awards "celebrates businesses, policies and nonprofits that are poised help shift society to a more sustainable and equitable future." The competition drew nearly 2,000 submissions across 17 categories. Fast Company editors and reporters created lists of honorable mentions and finalists and their panel of judges picked winners in each category.
Read more online or in the May print edition of the magazine.
More news media coverage
- Cincy Magazine: Higher Learning on the Rise: Guide to Colleges and Universities 2019
- Local 12: AntiOD: Naloxone kits to be available throughout downtown Cincinnati
- Cincinnati Enquirer: Naloxone boxes to be placed in Downtown Cincinnati in new bid to stem overdose deaths
- WLWT: DAAP professor's device makes it easier to access, use Narcan
- WVXU: Some Cincinnati buildings to get anti-overdose kits
- Spectrum News 1: UC students create lifesaving device for opioid overdose victims
- Medical Xpress: Design team creates a naloxone dispenser
- News-Medical: UC team designs new naloxone-dispensing smart device
- Bioengineer: University of Cincinnati design team creates a naloxone dispenser
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
A jolly good trip: Bearcats take on London for fragrance company
May 15, 2026
Six NEXT Innovation Scholars at the University of Cincinnati traveled to London to transform field research into actionable recommendations for British luxury bath, body and fragrance brand Molton Brown.
UC Blue Ash celebrates top students and recognizes Honor Student of the Year
May 14, 2026
The University of Cincinnati Blue Ash College recently hosted a special event that celebrated students for exceptional achievements during the 2025-26 academic year. The honorees included academic award winners, student engagement award winners, Latin Honors graduates, and the 2026 UC Blue Ash College Honor Student of the Year.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.